Promising Dengue Vaccine Faces Final Test
March 23, 2016
(Sci Dev Net) – A promising vaccine candidate to protect against dengue fever is undergoing a clinical trial in Brazil and could result in a new vaccine next year. The TV003 vaccine candidate was shown to fully protect against DENV-2, a strain of the dengue virus against which there are currently no safeguards. “During an earlier trial of the proposed vaccine, the United States National Institutes of Health gave a small group of adult volunteers the vaccine which is a mixture of weakened forms of all four dengue strains.